Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
Bank of New York Mellon Corp
> RVNC
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | 372,509 | 63,130 | 9,428,203,000 | -536,894,000 | $25,310.00 |
| 03/31/2023 | Revance Therapeutics, Inc. | RVNC | 309,379 | -3,316 | 9,965,097,000 | 4,192,747,000 | $32,210.00 |
| 12/31/2022 | Revance Therapeutics, Inc. | RVNC | 312,695 | 312,695 | 5,772,350,000 | 5,772,350,000 | $18,460.00 |
| 09/30/2022 | Revance Therapeutics, Inc. | RVNC | 0 | -258,964 | 0 | -3,579,000 | |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | 258,964 | -15,575 | 3,579,000 | -1,775,000 | $13.82 |
| 03/31/2022 | Revance Therapeutics, Inc. | RVNC | 274,539 | -1,705 | 5,354,000 | 846,000 | $19.50 |
| 12/31/2021 | Revance Therapeutics, Inc. | RVNC | 276,244 | 5,691 | 4,508,000 | -3,030,000 | $16.32 |
| 09/30/2021 | Revance Therapeutics, Inc. | RVNC | 270,553 | 19,775 | 7,538,000 | 105,000 | $27.86 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | 250,778 | -107,144 | 7,433,000 | -2,711,000 | $29.64 |
| 03/31/2021 | Revance Therapeutics, Inc. | RVNC | 0 | -357,922 | 0 | -10,144,000 | |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | 357,922 | 44,618 | 10,144,000 | 2,267,000 | $28.34 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | 313,304 | 33,933 | 7,877,000 | 1,055,000 | $25.14 |
| 06/30/2020 | Revance Therapeutics, Inc. | RVNC | 279,371 | 17,513 | 6,822,000 | 2,947,000 | $24.42 |
| 03/31/2020 | Revance Therapeutics, Inc. | RVNC | 261,858 | -66,006 | 3,875,000 | -1,445,000 | $14.80 |
| 12/31/2019 | Revance Therapeutics, Inc. | RVNC | 327,864 | -746,842 | 5,320,000 | -8,651,000 | $16.23 |
| 09/30/2019 | Revance Therapeutics, Inc. | RVNC | 1,074,706 | -1,179,091 | 13,971,000 | -15,262,000 | $13.00 |
| 06/30/2019 | Revance Therapeutics, Inc. | RVNC | 2,253,797 | -38,988 | 29,233,000 | -6,902,000 | $12.97 |
| 03/31/2019 | Revance Therapeutics, Inc. | RVNC | 2,292,785 | -249,457 | 36,135,000 | -15,040,000 | $15.76 |
| 01/29/2019 | Revance Therapeutics, Inc. | RVNC | 2,547,222 | 82,605 | 43,430,135 | -17,814,865 | $17.05 |
| 12/31/2018 | Revance Therapeutics, Inc. | RVNC | 2,542,242 | 77,625 | 51,175,000 | -10,070,000 | $20.13 |
| 09/30/2018 | Revance Therapeutics, Inc. | RVNC | 2,464,617 | 519,938 | 61,245,000 | 7,864,000 | $24.85 |
| 06/30/2018 | Revance Therapeutics, Inc. | RVNC | 1,944,679 | -68,553 | 53,381,000 | -8,626,000 | $27.45 |
| 03/31/2018 | Revance Therapeutics, Inc. | RVNC | 2,013,232 | -131,437 | 62,007,000 | -14,665,000 | $30.80 |
| 12/31/2017 | Revance Therapeutics, Inc. | RVNC | 2,144,669 | 135,356 | 76,672,000 | 21,316,000 | $35.75 |
| 09/30/2017 | Revance Therapeutics, Inc. | RVNC | 2,009,313 | -70,249 | 55,356,000 | 455,000 | $27.55 |
| 06/30/2017 | Revance Therapeutics, Inc. | RVNC | 2,079,562 | 261,764 | 54,901,000 | 17,091,000 | $26.40 |
| 03/31/2017 | Revance Therapeutics, Inc. | RVNC | 1,817,798 | -123,932 | 37,810,000 | -2,384,000 | $20.80 |
| 12/31/2016 | Revance Therapeutics, Inc. | RVNC | 1,941,730 | 18,622 | 40,194,000 | 9,019,000 | $20.70 |
| 09/30/2016 | Revance Therapeutics, Inc. | RVNC | 1,923,108 | 1,923,108 | 31,175,000 | 31,175,000 | $16.21 |
| 06/30/2016 | Revance Therapeutics, Inc. | RVNC | 2,118,558 | 152,383 | 28,812,000 | -5,517,000 | $13.60 |
| 03/31/2016 | Revance Therapeutics, Inc. | RVNC | 1,966,175 | -43,392 | 34,329,000 | -34,318,000 | $17.46 |
| 12/31/2015 | Revance Therapeutics, Inc. | RVNC | 2,009,567 | 98,080 | 68,647,000 | 11,760,000 | $34.16 |
| 09/30/2015 | Revance Therapeutics, Inc. | RVNC | 1,911,487 | 71,346 | 56,887,000 | -1,961,000 | $29.76 |
| 06/30/2015 | Revance Therapeutics, Inc. | RVNC | 1,840,141 | 1,730,714 | 58,848,000 | 55,126,000 | $31.98 |
| 03/31/2015 | Revance Therapeutics, Inc. | RVNC | 1,164,294 | 140,872 | 24,136,000 | 6,799,000 | $20.73 |
| << Prev Next >> |
|